electronic currency trading for maximum profit, Overview

Russia is willing to engage with the United States on the Ukrainian issue. Russian Foreign Ministry spokesman Zacharova said at a regular press conference on the 11th that Russia is willing to engage with the United States on the Ukrainian issue, but has not received any "serious suggestions" from the team of President-elect Trump.US natural gas futures rose 6% in the day, and US natural gas futures rose 6% in the day, and are now reported at $3.353 per million British heat.LambdaTest received $38 million in financing, and Qualcomm Venture Capital participated in the investment. On December 12th, LambdaTest, a unified cloud testing platform, announced that the company had received $38 million in financing led by Avataar Ventures and invested by Qualcomm Venture Capital, with a total financing amount of $108 million. Founded in 2017, LambdaTest has raised nearly $70 million from investors in previous rounds of financing, including Premji Invest, Sequoia Capital India, Titanium Ventures, Leo Capital Holdings and Blume Ventures.

Jinmo Technology: The reserve price for the transfer of 40% equity of Mo Tian Jun Fu is 9,980,600 yuan. Jinmo Technology announced that the company held the 28th meeting of the 4th Board of Directors on November 29th, 2024, and reviewed and approved the Proposal on Authorizing the General Manager's Office to Transfer the Equity of Joint Venture. Authorized by the resolution of the board of directors, the company entrusted Southwest United Assets and Equity Exchange to publicly list and transfer 40% equity of Beijing Mo Tian Jun Fu Private Equity Fund Management Co., Ltd., with a reserve price of 9,980,600 yuan. Aerofilm Technology Development Group Co., Ltd. became the final transferee, with a transaction price of 9,980,600 yuan. Aerofilm Technology holds 23.63% shares of Jinmo Technology, which is the controlling shareholder of the company and also the shareholder holding more than 5% shares. This transaction constitutes a connected transaction.Dashengda and Tuopai Shede Group set up investment partnerships. According to the enterprise search APP, Sichuan Fujiang Yingke Investment Partnership (Limited Partnership) was recently established with a capital contribution of 200 million yuan. Its business scope includes: asset management services invested by its own funds; Enterprise management consulting; Information technology consulting service. Enterprise equity penetration shows that the enterprise is jointly held by Dashengda and Sichuan Tuopai Shede Group Co., Ltd..Since January 1, 2025, Chongqing maternity allowance has been issued to the insured female employees themselves. Recently, Chongqing Medical and Social Security Bureau issued the Notice on Adjusting the Payment Method for Maternity Insurance Benefits, and adjusted the payment method for maternity insurance benefits. From January 1, 2025, the application and method of maternity insurance benefits for the insured shall be applied by the insured himself or his client and issued to him by the medical insurance agency. In order to optimize the processing flow of maternity allowance, the service of "enjoy the maternity allowance immediately upon application" has been opened, that is, when the designated medical institutions in Chongqing settle the maternity medical expenses (delivery and termination of pregnancy), the medical insurance system automatically obtains the maternity-related information to calculate the maternity allowance, and the maternity allowance is paid to the insured after being approved by the medical insurance agency, and the insured or their clients do not need to provide relevant information to the medical insurance agency to declare the offline maternity allowance.

The monkeypox vaccine with independent intellectual property rights in China was approved for clinical use. On December 10th, the monkeypox vaccine jointly developed by China Bio-Beijing Institute of Biological Products and China Center for Disease Control and Prevention received the approval notice of drug clinical trial issued by National Medical Products Administration, and it was registered and classified as Class 1.2 innovative vaccine. The vaccine is an innovative vaccine independently developed by scientists in China with completely independent intellectual property rights, which is expected to play an important role in the prevention and control of diseases caused by monkeypox virus in China. (China Biology)On the 12th, the South Korean National Assembly voted to impeach the Minister of Justice Park Hyung-jae and the Director of the Police Department Zhao Zhihao.The Nikkei 225 index just broke through the 39,900.00 mark, and the latest report was 39,899.07, up 1.34% in the day.